Phthalic Acid

Phthalic Acid

SCHEMBL368383

C=CO.O=C(O)c1ccccc1C(=O)O

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.74
ALOX15 P16050 1/20 0.74
AKR1C3 P42330 3/20 0.56
KDM4E B2RXH2 2/20 0.54
HPGD P15428 2/20 0.54
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
HMGB1 P09429 1/20 0.54
CA4 P22748 1/20 0.54
CA6 P23280 1/20 0.54
CA7 P43166 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
CA9 Q16790 1/20 0.54
NAPRT Q6XQN6 1/20 0.54
CA14 Q9ULX7 1/20 0.54
MAPT P10636 2/20 0.52
HDAC8 Q9BY41 1/20 0.52
POLB P06746 1/20 0.50
CDC25B P30305 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalic Acid SCHEMBL28849612 1.00 ALDH1A1 (0.74) ALDH1A1ALOX15AKR1C3KDM4EHPGD
Phthalic Acid SCHEMBL2171614 0.93 ALDH1A1 (0.64) ALDH1A1ALOX15AKR1C3KDM4EHPGD
Phthalic Acid SCHEMBL2316524 0.90 ALDH1A1 (0.74) ALDH1A1ALOX15AKR1C3KDM4EHPGD
Phthalic Acid SCHEMBL9722583 0.87 ALDH1A1 (0.70) ALDH1A1ALOX15AKR1C3KDM4EHPGD
Phthalic Acid SCHEMBL9015682 0.87 ALDH1A1 (0.70) ALDH1A1ALOX15AKR1C3KDM4EHPGD
Phthalic Acid SCHEMBL29462501 0.87 ALDH1A1 (0.70) ALDH1A1ALOX15AKR1C3KDM4EHPGD
Phthalic Acid SCHEMBL8507781 0.87 ALDH1A1 (0.70) ALDH1A1ALOX15AKR1C3KDM4EHPGD
Phthalic Acid SCHEMBL9015687 0.87 ALDH1A1 (0.70) ALDH1A1ALOX15AKR1C3KDM4EHPGD
Phthalic Acid SCHEMBL335928 0.87 ALDH1A1 (0.70) ALDH1A1ALOX15AKR1C3KDM4EHPGD
Phthalic Acid SCHEMBL7192838 0.87 ALDH1A1 (0.70) ALDH1A1ALOX15AKR1C3KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107204343-B Flexible display and forming method thereof SHANGHAI TIANMA MICROELECTRONICS Co.,Ltd. (CN) 2019-10-29 CN claimed
CN-110120412-A Flexible display apparatus and its manufacturing method 三星显示有限公司 2019-08-13 CN claimed
CN-104241295-B Flexible display device and method of manufacturing the same 三星显示有限公司 2019-06-28 CN claimed
CN-106206652-B Organic light-emitting display device 乐金显示有限公司 2019-04-12 CN claimed
CN-108351722-A Film touch sensing 东友精细化工有限公司 2018-07-31 CN claimed
CN-104576684-B OLED and its manufacture method 乐金显示有限公司 2018-01-30 CN claimed
CN-107204343-A Flexible display and forming method thereof 上海天马微电子有限公司 2017-09-26 CN claimed
CN-106206652-A Organic light-emitting display device 乐金显示有限公司 2016-12-07 CN claimed
EP-2542223-B1 COMPLEX FORMULATION FOR ORAL ADMINISTRATION COMPRISING PROBIOTIC FORMULATION AND 5-HT4 RECEPTOR AGONIST AND METHOD FOR THE PREPARATION THEREOF HANMI SCIENCE CO LTD (KR) 2015-09-23 EP claimed
CN-102136551-B Polymer substrate and method of manufacturing the same, display device including the polymer substrate and method of manufacturing the display device SAMSUNG DISPLAY CO LTD 2015-05-06 CN claimed
EP-2180891-A2 COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME Hanall Pharmaceutical Co., Ltd. (KR) 2010-05-05 EP claimed
US-20100047341-A1 COMBINED PREPARATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THEORY HANALL PHARMACEUTICAL CO., LTD. (KR) 2010-02-25 US claimed
EP-2079451-A1 COMBINED PREPARATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THEORY Hanall Pharmaceutical Co., Ltd. (KR) 2009-07-22 EP claimed
WO-2009022821-A2 COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME HANALL PHARMACEUTICAL COMPANY. LTD (KR) 2009-02-19 WO claimed
WO-2008044862-A1 COMBINED PREPARATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THEORY HANALL PHARMACEUTICAL CO., LTD. (KR) 2008-04-17 WO claimed
WO-1998026767-A2 SITE-SPECIFIC CONTROLLED RELEASE DOSAGE FORMULATION FOR MESALAMINE POLI INDUSTRIA CHIMICA S.P.A. (IT) 1998-06-25 WO claimed
EP-0241178-B1 PHARMACEUTICAL COMPOSITION FOR TREATING PERIODONTAL DISEASES ROHTO PHARMACEUTICAL CO., LTD. (JP) 1992-01-08 EP claimed
EP-0241179-B1 PHARMACEUTICAL COMPOSITION FOR PERIODONTAL DISEASES ROHTO PHARMACEUTICAL CO., LTD. (JP) 1991-11-13 EP claimed
US-4981693-A Pharmaceutical composition for periodontal diseases ROHTO PHARMACEUTICAL CO., LTD. (JP) 1991-01-01 US claimed
US-4933182-A Pharmaceutical composition for treating periodontal ROHTO PHARMACEUTICAL CO. LTD. (JP) 1990-06-12 US claimed